Octacosanoic acid, 14,17,18-trihydroxy-20-methyl-, methyl ester,(14S,17S,18S,20S)- (651032-49-4)

Identification
Name:	Octacosanoic acid, 14,17,18-trihydroxy-20-methyl-, methyl ester,(14S,17S,18S,20S)-
CAS:	651032-49-4
Molecular Formula:	C₃₀H₆₀O₅
Molecular Structure:
Properties
Safety Data

Other Product

Ibogamine-18-carboxylic acid,20-hydroxy-14-[(3R)-16-(hydroxymethyl)- 17-methoxy-17-oxovobasan-3-yl]- 13-methoxy-,methyl ester,(20S)-
(17S,20S)-17-Methyl-20-[(2S,5S)-5-methyl-2-piperidyl]-18-norpregna-5,12-diene-3β,16β-diol
14-[(3S,20S)-19,20-Dihydro-17-methoxy-17-oxovobasan-3-yl]-13-methoxyibogamine-18-carboxylic acid methyl ester
(4α,20S)-20-Hydroxyibogamine-18-carboxylic acid methyl ester
(20S)-2,16-Didehydro-20-hydroxycuran-17-oic acid methyl ester
Ibogamine-18-carboxylic acid,14-[(3R)-16-(hydroxymethyl)-17- methoxy-17-oxovobasan-3-yl]-13-methoxy- 20-oxo-,methyl ester
9,8,14-[1]Buten[1]yl[4]ylideneanthra[1,2-b]benz[f]azocine-19-carboxylicacid,8-chloro-5,8,9,14,15,16-hexahydro-1,4,6,17-tetrahydroxy-20-methoxy-18-methyl-5,16-dioxo-,(8R,9R,14S,17S,18S)- (9CI)
9,8,14-[1]Buten[1]yl[4]ylideneanthra[1,2-b]benz[f]azocine-19-carboxylicacid,5,8,9,14,15,16-hexahydro-1,4,6,8,17-pentahydroxy-20-methoxy-18-methyl-5,16-dioxo-,(8R,9S,14S,17S,18S)- (9CI)
Ibogamine-18-carboxylic acid,20-hydroxy-12-[(3R)-16-(hydroxymethyl)- 17-methoxy-17-oxovobasan-3-yl]- 13-methoxy-,methyl ester,(20S)-
(3α,14S,16α)-14,15-Dihydro-14-hydroxy-20-oxoeburnamenine-14-carboxylic acid methyl ester
Ibogamine-18-carboxylicacid, 20-hydroxy-12-methoxy-, methyl ester, (20S)-
18-Norpregna-3,5,12-triene,17-methyl-20- [(2S,5R)-5-methyl-2-piperidinyl]-,(20S)-
[(8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxyphosphonic acid
Ibogamine-18-carboxylic acid, 14-((3alpha)-17-methoxy-17-oxovobasan-3- yl)-, methyl ester
2,4,10,12-Nonadecatetraenoicacid,7,15,17-trihydroxy-2,14-dimethoxy-4,6,8,10,16-pentamethyl-18-[(4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-,methyl ester, (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S)-
2,4,10,12-Nonadecatetraenoicacid,7,15,17-trihydroxy-2,14-dimethoxy-4,6,8,10,16-pentamethyl-18-[(4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-,methyl ester, (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S)-
(5S,14S,17S)-14-benzyl-5-(4-hydroxybenzyl)-17-(2-(methylthio)ethyl)-1-(3-nitro-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-3,6,9,12,15-pentaoxo-2-oxa-4,7,10,13,16-pentaazaoctadecan-18-oic acid
(3S,8S,9S,10R,13S,14S,17S)-3-HYDROXY-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-17-CARBOXYLIC ACID METHYL ESTER
9,8,14-[1]Butanyl[4]ylideneanthra[1,2-b]benz[f]azocine-5,16,19-trione,8,9,14,15-tetrahydro-1,4,6,8,10,17-hexahydroxy-20-methoxy-18-methyl-,(8R,9R,14S,17S,18R)- (9CI)
9,8,14-[1]Butanyl[4]ylideneanthra[1,2-b]benz[f]azocine-5,16,19-trione,8,9,14,15-tetrahydro-1,4,6,8,17-pentahydroxy-20-methoxy-18-methyl-,(8R,9R,14S,17S,18R)- (9CI)